Schedule 13G ownership disclosure
Sunesis Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 867328700
Event date: 2017-10-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 35,968,401
- Percent of class
- 10.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-17-058395
- Form type
- SC 13G
- Filer
- RA CAPITAL MANAGEMENT, L.P.
- CIK
- CIK 1346824
- Filed
- Nov 13, 2017
- Reporting period
- Oct 25, 2017
- Description
- Schedule 13G beneficial ownership